Collaboration integrates AI discovery, human brain organoid modeling, and in vivo validation to generate differentiated neurology assets for pharmaceutical partnering and development SACRAMENTO, Calif. and SAN DIEGO, May 28, 2026 /PRNewswire/ — Lunai Bioworks’ (NASDAQ: LNAI) wholly owned…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
